Redhill Biopharma
RDHL
#10477
Rank
ยฃ2.97 M
Marketcap
ยฃ0.89
Share price
-0.83%
Change (1 day)
-84.75%
Change (1 year)

Revenue for Redhill Biopharma (RDHL)

Revenue in 2022: ยฃ51.08 Million

According to Redhill Biopharma's latest financial reports the company's current revenue (TTM ) is ยฃ26.83 Million. In 2022 the company made a revenue of ยฃ51.08 Million a decrease over the revenue in the year 2021 that were of ยฃ63.53 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Redhill Biopharma from 2012 to 2022

Annual revenue

Year Revenue Change
2022ยฃ51.08 M-19.59%
2021ยฃ63.53 M34.55%
2020ยฃ47.21 M884.18%
2019ยฃ4.79 M-27.16%
2018ยฃ6.58 M122.14%
2017ยฃ2.96 M3522.11%
2016ยฃ0.08 M3943.37%
2015ยฃ0 M-99.96%
2014ยฃ4.5 M61826.69%
2013ยฃ0 M-26.51%
2012ยฃ0 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sanofi
SNY
ยฃ35.67 B 132,855.88%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ48.21 B 179,603.46%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ31.79 B 118,385.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Taro Pharmaceutical
TARO
ยฃ0.45 B 1,608.85%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Teva Pharmaceutical Industries
TEVA
ยฃ12.59 B 46,832.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel